vs
Side-by-side financial comparison of GCI Liberty, Inc. (GLIBA) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $257.0M, roughly 1.5× GCI Liberty, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs -150.6%, a 155.8% gap on every dollar of revenue.
GCI Communication Corp (GCI) is a telecommunications corporation operating in Alaska. Through its own facilities and agreements with other providers, GCI provides Internet access, landline, and cellular telephone service. It is a subsidiary of GCI Liberty, Inc.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
GLIBA vs GRDN — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $257.0M | $397.6M |
| Net Profit | $-387.0M | $20.9M |
| Gross Margin | — | 21.5% |
| Operating Margin | -189.9% | 7.7% |
| Net Margin | -150.6% | 5.3% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $-13.34 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $397.6M | ||
| Q3 25 | $257.0M | $377.4M | ||
| Q2 25 | $261.0M | $344.3M | ||
| Q1 25 | — | $329.3M | ||
| Q3 24 | — | $314.4M |
| Q4 25 | — | $20.9M | ||
| Q3 25 | $-387.0M | $9.8M | ||
| Q2 25 | $27.0M | $9.0M | ||
| Q1 25 | — | $9.4M | ||
| Q3 24 | — | $-122.0M |
| Q4 25 | — | 21.5% | ||
| Q3 25 | — | 19.8% | ||
| Q2 25 | — | 19.8% | ||
| Q1 25 | — | 19.5% | ||
| Q3 24 | — | 19.4% |
| Q4 25 | — | 7.7% | ||
| Q3 25 | -189.9% | 4.3% | ||
| Q2 25 | 19.5% | 3.7% | ||
| Q1 25 | — | 3.9% | ||
| Q3 24 | — | -33.3% |
| Q4 25 | — | 5.3% | ||
| Q3 25 | -150.6% | 2.6% | ||
| Q2 25 | 10.3% | 2.6% | ||
| Q1 25 | — | 2.9% | ||
| Q3 24 | — | -38.8% |
| Q4 25 | — | — | ||
| Q3 25 | $-13.34 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $124.0M | $65.6M |
| Total DebtLower is stronger | $985.0M | $0 |
| Stockholders' EquityBook value | $1.4B | $217.9M |
| Total Assets | $3.0B | $412.7M |
| Debt / EquityLower = less leverage | 0.72× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $65.6M | ||
| Q3 25 | $124.0M | $36.5M | ||
| Q2 25 | $104.0M | $18.8M | ||
| Q1 25 | — | $14.0M | ||
| Q3 24 | — | $37.2M |
| Q4 25 | — | $0 | ||
| Q3 25 | $985.0M | — | ||
| Q2 25 | $987.0M | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $34.3M |
| Q4 25 | — | $217.9M | ||
| Q3 25 | $1.4B | $195.5M | ||
| Q2 25 | — | $179.7M | ||
| Q1 25 | — | $163.2M | ||
| Q3 24 | — | $133.9M |
| Q4 25 | — | $412.7M | ||
| Q3 25 | $3.0B | $390.0M | ||
| Q2 25 | $3.4B | $356.3M | ||
| Q1 25 | — | $334.0M | ||
| Q3 24 | — | $348.0M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $76.0M | $34.6M |
| Free Cash FlowOCF − Capex | $21.0M | — |
| FCF MarginFCF / Revenue | 8.2% | — |
| Capex IntensityCapex / Revenue | 21.4% | — |
| Cash ConversionOCF / Net Profit | — | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $34.6M | ||
| Q3 25 | $76.0M | $28.2M | ||
| Q2 25 | $226.0M | $19.9M | ||
| Q1 25 | — | $17.6M | ||
| Q3 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $21.0M | $24.2M | ||
| Q2 25 | $107.0M | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 8.2% | 6.4% | ||
| Q2 25 | 41.0% | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 21.4% | 1.1% | ||
| Q2 25 | 45.6% | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
| Q4 25 | — | 1.65× | ||
| Q3 25 | — | 2.87× | ||
| Q2 25 | 8.37× | 2.21× | ||
| Q1 25 | — | 1.86× | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
